Abstract
A total of 410 proved cases of neonatal septicaemia from seven Finnish hospitals seen between 1976 and 1980 were reviewed. The annual incidence of neonatal septicaemia was 3 per 1000 births, and overall mortality was 23%. Onset was early in most patients. Symptoms of septicaemia occurred within the first 24 hours of life in 44% and within the first week of life in 90%. In the very early onset disease (within 24 hours) mortality was 30%, compared with 17% in all other cases. Group B streptococcus was the leading cause in very early onset disease (52%) but mortality from infection with this organism was similar to that in other very early onset cases. It is concluded that very early onset neonatal septicaemia, probably of intrauterine origin and caused by group B streptococcus in one half of the cases, constitutes the major form of neonatal septicaemia in Finland and should receive the highest priority in preventive measures.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anthony B. F., Okada D. M. The emergence of group B streptococci in infections of the newborn infant. Annu Rev Med. 1977;28:355–369. doi: 10.1146/annurev.me.28.020177.002035. [DOI] [PubMed] [Google Scholar]
- Baker C. J. Early onset group B streptococcal disease. J Pediatr. 1978 Jul;93(1):124–125. doi: 10.1016/s0022-3476(78)80623-4. [DOI] [PubMed] [Google Scholar]
- Baker C. J., Edwards M. S., Kasper D. L. Immunogenicity of polysaccharides from type III, group B Streptococcus. J Clin Invest. 1978 Apr;61(4):1107–1110. doi: 10.1172/JCI109011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bennet R., Eriksson M., Zetterström R. Increasing incidence of neonatal septicemia: causative organism and predisposing risk factors. Acta Paediatr Scand. 1981 Mar;70(2):207–210. doi: 10.1111/j.1651-2227.1981.tb05543.x. [DOI] [PubMed] [Google Scholar]
- Bergqvist G., Eriksson M., Zetterström R. Neonatal septicemia and perinatal risk factors. Acta Paediatr Scand. 1979 May;68(3):337–339. doi: 10.1111/j.1651-2227.1979.tb05016.x. [DOI] [PubMed] [Google Scholar]
- Christensen K. K., Christensen P., Hägerstrand I., Lindén V., Nordbring F., Svenningsen N. The clinical significance of group B streptococci. J Perinat Med. 1982;10(3):133–146. [PubMed] [Google Scholar]
- Evaldson G., Nord C. E. Amniotic fluid activity against Bacteroides fragilis and group B streptococci. Med Microbiol Immunol. 1981;170(1):11–17. doi: 10.1007/BF02123792. [DOI] [PubMed] [Google Scholar]
- Jeffery H., Mitchison R., Wigglesworth J. S., Davies P. A. Early neonatal bacteraemia. Comparison of group B streptococcal, other Gram-positive and Gram-negative infections. Arch Dis Child. 1977 Sep;52(9):683–686. doi: 10.1136/adc.52.9.683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jelínkoá J. Group B streptococci in the human population. Curr Top Microbiol Immunol. 1977;76:127–165. [PubMed] [Google Scholar]
- Johnson D. R., Ferrieri P. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes. J Clin Microbiol. 1984 Apr;19(4):506–510. doi: 10.1128/jcm.19.4.506-510.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parker M. T. Perinatal and neonatal infections: infections with group-B streptococci. J Antimicrob Chemother. 1979 May;5 (Suppl A):27–37. doi: 10.1093/jac/5.supplement_a.27. [DOI] [PubMed] [Google Scholar]
- Placzek M. M., Whitelaw A. Early and late neonatal septicaemia. Arch Dis Child. 1983 Sep;58(9):728–731. doi: 10.1136/adc.58.9.728. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sherman M., Goldstein E., Lippert W., Wennberg R. Group B streptococcal lung infection in neonatal rabbits. Pediatr Res. 1982 Mar;16(3):209–212. doi: 10.1203/00006450-198203000-00009. [DOI] [PubMed] [Google Scholar]